Global Retirement Partners, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Global Retirement Partners, LLC
- $3.25 Billion
- Q3 2024
A detailed history of Global Retirement Partners, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 45 shares of RARE stock, worth $2,282. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 45
-0.0%
Holding current value
$2,282
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RARE
# of Institutions
293Shares Held
88.2MCall Options Held
535KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA9.78MShares$496 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$284 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.35MShares$272 Million0.68% of portfolio
-
Wellington Management Group LLP Boston, MA4.56MShares$231 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$165 Million2.24% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.55B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...